ASPE
Aspen Neuroscience Inc.
NASDAQ · Healthcare · Biotechnology · US
$12.76
+3.82%4
Insider buys (3m)
0
Insider sells (3m)
$38.0M
Net value (3m)
—
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Nov 2, 2026 | ARCH Venture Fund X, L.P. · 10 percent owner | Purchase | 66,666 | $15 |
| Nov 2, 2026 | ARCH Venture Fund X, L.P. · 10 percent owner | Purchase | 66,667 | $15 |
| Nov 2, 2026 | ARCH Venture Fund X, L.P. · 10 percent owner | Purchase | 1,200,000 | $15 |
| Nov 2, 2026 | ARCH Venture Partners XIV, L.P. · 10 percent owner | Purchase | 1,200,000 | $15 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Nov 2, 2026